vs

Side-by-side financial comparison of Claritev Corp (CTEV) and CareTrust REIT, Inc. (CTRE). Click either name above to swap in a different company.

Claritev Corp is the larger business by last-quarter revenue ($246.6M vs $134.9M, roughly 1.8× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -32.7%, a 115.2% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 6.2%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 2.5%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

CTEV vs CTRE — Head-to-Head

Bigger by revenue
CTEV
CTEV
1.8× larger
CTEV
$246.6M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+48.9% gap
CTRE
55.1%
6.2%
CTEV
Higher net margin
CTRE
CTRE
115.2% more per $
CTRE
82.5%
-32.7%
CTEV
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
2.5%
CTEV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTEV
CTEV
CTRE
CTRE
Revenue
$246.6M
$134.9M
Net Profit
$-80.6M
$111.3M
Gross Margin
Operating Margin
-3.1%
Net Margin
-32.7%
82.5%
Revenue YoY
6.2%
55.1%
Net Profit YoY
41.6%
113.5%
EPS (diluted)
$-4.88
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
CTRE
CTRE
Q4 25
$246.6M
$134.9M
Q3 25
$246.0M
$132.4M
Q2 25
$241.6M
$112.5M
Q1 25
$231.3M
$96.6M
Q4 24
$232.1M
$86.9M
Q3 24
$230.5M
$77.4M
Q2 24
$233.5M
$68.9M
Q1 24
$234.5M
$63.1M
Net Profit
CTEV
CTEV
CTRE
CTRE
Q4 25
$-80.6M
$111.3M
Q3 25
$-69.8M
$74.9M
Q2 25
$-62.6M
$68.5M
Q1 25
$-71.3M
$65.8M
Q4 24
$-138.0M
$52.1M
Q3 24
$-391.4M
$33.4M
Q2 24
$-576.7M
$10.8M
Q1 24
$-539.7M
$28.7M
Operating Margin
CTEV
CTEV
CTRE
CTRE
Q4 25
-3.1%
Q3 25
4.1%
58.1%
Q2 25
6.9%
61.3%
Q1 25
4.2%
Q4 24
-17.8%
Q3 24
-146.7%
43.0%
Q2 24
-224.4%
15.1%
Q1 24
-207.4%
Net Margin
CTEV
CTEV
CTRE
CTRE
Q4 25
-32.7%
82.5%
Q3 25
-28.4%
56.6%
Q2 25
-25.9%
60.9%
Q1 25
-30.8%
68.1%
Q4 24
-59.4%
60.0%
Q3 24
-169.8%
43.2%
Q2 24
-247.0%
15.6%
Q1 24
-230.1%
45.6%
EPS (diluted)
CTEV
CTEV
CTRE
CTRE
Q4 25
$-4.88
$0.52
Q3 25
$-4.23
$0.35
Q2 25
$-3.81
$0.35
Q1 25
$-4.38
$0.35
Q4 24
$-8.49
$0.30
Q3 24
$-24.25
$0.21
Q2 24
$-35.78
$0.07
Q1 24
$-33.40
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
CTRE
CTRE
Cash + ST InvestmentsLiquidity on hand
$16.8M
$198.0M
Total DebtLower is stronger
$4.6B
$894.2M
Stockholders' EquityBook value
$-173.9M
$4.0B
Total Assets
$4.9B
$5.1B
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
CTRE
CTRE
Q4 25
$16.8M
$198.0M
Q3 25
$39.2M
$712.5M
Q2 25
$56.4M
$306.1M
Q1 25
$23.1M
$26.5M
Q4 24
$16.8M
$213.8M
Q3 24
$86.6M
$377.1M
Q2 24
$48.8M
$495.1M
Q1 24
$58.7M
$451.2M
Total Debt
CTEV
CTEV
CTRE
CTRE
Q4 25
$4.6B
$894.2M
Q3 25
$4.5B
$893.8M
Q2 25
$4.5B
$1.2B
Q1 25
$4.5B
$822.1M
Q4 24
$4.5B
$396.9M
Q3 24
$4.5B
$396.7M
Q2 24
$4.5B
$671.1M
Q1 24
$4.5B
$595.9M
Stockholders' Equity
CTEV
CTEV
CTRE
CTRE
Q4 25
$-173.9M
$4.0B
Q3 25
$-101.8M
$4.0B
Q2 25
$-39.9M
$3.3B
Q1 25
$14.8M
$2.9B
Q4 24
$84.0M
$2.9B
Q3 24
$207.6M
$2.4B
Q2 24
$603.4M
$1.9B
Q1 24
$1.2B
$1.7B
Total Assets
CTEV
CTEV
CTRE
CTRE
Q4 25
$4.9B
$5.1B
Q3 25
$5.0B
$5.1B
Q2 25
$5.1B
$4.7B
Q1 25
$5.1B
$3.9B
Q4 24
$5.2B
$3.4B
Q3 24
$5.3B
$2.9B
Q2 24
$5.7B
$2.7B
Q1 24
$6.4B
$2.3B
Debt / Equity
CTEV
CTEV
CTRE
CTRE
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
304.87×
0.28×
Q4 24
53.67×
0.14×
Q3 24
21.73×
0.16×
Q2 24
7.48×
0.35×
Q1 24
3.85×
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
CTRE
CTRE
Operating Cash FlowLast quarter
$66.3M
$394.0M
Free Cash FlowOCF − Capex
$36.4M
FCF MarginFCF / Revenue
14.8%
Capex IntensityCapex / Revenue
12.1%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$-12.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
CTRE
CTRE
Q4 25
$66.3M
$394.0M
Q3 25
$19.9M
$100.9M
Q2 25
$61.2M
$100.8M
Q1 25
$-30.1M
$71.4M
Q4 24
$-33.4M
$244.3M
Q3 24
$72.8M
$67.2M
Q2 24
$18.5M
$53.0M
Q1 24
$49.7M
$48.8M
Free Cash Flow
CTEV
CTEV
CTRE
CTRE
Q4 25
$36.4M
Q3 25
$-16.3M
Q2 25
$36.6M
Q1 25
$-68.9M
Q4 24
$-63.8M
Q3 24
$41.1M
Q2 24
$-7.0M
Q1 24
$19.2M
FCF Margin
CTEV
CTEV
CTRE
CTRE
Q4 25
14.8%
Q3 25
-6.6%
Q2 25
15.2%
Q1 25
-29.8%
Q4 24
-27.5%
Q3 24
17.8%
Q2 24
-3.0%
Q1 24
8.2%
Capex Intensity
CTEV
CTEV
CTRE
CTRE
Q4 25
12.1%
Q3 25
14.7%
Q2 25
10.2%
Q1 25
16.8%
Q4 24
13.1%
Q3 24
13.8%
Q2 24
10.9%
Q1 24
13.0%
Cash Conversion
CTEV
CTEV
CTRE
CTRE
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons